Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI: Randomized, Placebo-Controlled Phase II Clinical Trial in Patients with Latent Tuberculosis Infe...

por Nell, Andre S., D’lom, Eva, Bouic, Patrick, Sabaté, Montserrat, Bosser, Ramon, Picas, Jordi, Amat, Mercè, Churchyard, Gavin, Cardona, Pere-Joan
Publicado 2014

RUTI Vaccination Enhances Inhibition of Mycobacterial Growth ex vivo and Induces a Shift of Monocyte Phenotype in Mice

por Prabowo, Satria A., Painter, Hannah, Zelmer, Andrea, Smith, Steven G., Seifert, Karin, Amat, Merce, Cardona, Pere-Joan, Fletcher, Helen A.
Publicado 2019

Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS)

por Pennisi, Marzio, Russo, Giulia, Sgroi, Giuseppe, Bonaccorso, Angela, Parasiliti Palumbo, Giuseppe Alessandro, Fichera, Epifanio, Mitra, Dipendra Kumar, Walker, Kenneth B., Cardona, Pere-Joan, Amat, Merce, Viceconti, Marco, Pappalardo, Francesco
Publicado 2019